Trailing-twelve-month (TTM) revenue is $8.00 Billion with a year-over-year growth of +14.17%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-27 | $1,704,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q2 FY2026Period ended 2025-12-27 | $2,502,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q3 FY2026Period ended 2026-03-28 | $1,920,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q4 FY2026Period ended 2026-06-27 | $1,876,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $8,004,200,000 |
Current P/S: $22,338,095,200 market capitalization ÷ $8,004,200,000 TTM revenue = 2.79x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T19:59:59.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-27): $1.88B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T20:16:16.083Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-06-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-07-03 · USD | FY20222022-07-02 · USD | FY20232023-07-01 · USD | FY20242024-06-29 · USD | FY20252025-06-28 · USD | FY20262026-06-27 · USD |
|---|---|---|---|---|---|---|
| Coach Segment | $4.3B | $4.9B | $5.0B | $5.1B | $5.6B | $6.9B |
| Kate Spade & Company | $1.2B | $1.4B | $1.4B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-07-03 · USD | FY20222022-07-02 · USD | FY20232023-07-01 · USD | FY20242024-06-29 · USD | FY20252025-06-28 · USD | FY20262026-06-27 · USD |
|---|---|---|---|---|---|---|
| Greater China | $1.1B | $1.0B | $1.0B | $1.0B | $1.1B | $1.4B |
| Non-US | $687M | $905M | $1.0B | $1.2B |
$8.00B
$8.00 Billion
+14.17%
vs. $7.01B a year ago (TTM)
+10.03%
5 Year compound annual growth rate
1 Year
+14.17%
3 Year
+5.81%
5 Year
+10.03%
10 Year
+6.15%
15 Year
+4.53%
20 Year
+7.10%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $8.00B | +$993.50M | +14.17% |
| 2025 | $7.01B | +$339.50M | +5.09% |
| 2024 | $6.67B | +$10.30M | +0.15% |
| 2023 | $6.66B | ($23.60M) | (0.35%) |
| 2022 | $6.68B | +$938.20M | +16.33% |
| 2021 |
TTM Growth
+14.17%
3-Year CAGR
+5.81%
5-Year CAGR
+10.03%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T20:16:16.083Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.2B |
| $1.1B |
| Stuart Weitzman | $283M | $318M | $282M | $242M | $215M | $15M |
|---|
| $1.4B |
| North America | $3.4B | $4.2B | $4.0B | $3.9B | $4.2B | $4.7B |
|---|
| Other Asia | $599M | $579M | $569M | $554M | $515M | $466M |
|---|
| $5.75B |
| +$784.90M |
| +15.82% |
| 2020 | $4.96B | ($1.07B) | (17.68%) |
| 2019 | $6.03B | +$147.10M | +2.50% |
| 2018 | $5.88B | +$1.39B | +31.01% |
| 2017 | $4.49B | ($3.50M) | (0.08%) |
